在服用elexacaftor/tezacaftor/ivacaftor (ETI) 时"健康"意味着什么? 一个定性研究研究
Robin S Everhart1, Emma McWilliams2, Jill Maggs3
1Department of Psychology, Virginia Commonwealth University, Richmond, VA, USA.
概括
埃莱克萨卡夫托尔/特萨卡夫托尔/伊瓦卡夫托尔 (ETI) 显著改善了CF患者的健康状况,导致自我认同的转变,并专注于超越身体改善的整体健康. 这凸显了不断发展的CF护理策略的必要性.
科学领域:
- 医学研究 医学研究
- 囊性纤维化治疗药物治疗方法
- 患者报告的结果
背景情况:
- 埃莱克萨卡夫托/特萨卡夫托/伊瓦卡夫托 (ETI) 已经改变了患有囊性纤维化 (pwCF) 的人的健康结果.
- 深刻的健康变化促使pwCF重新评估他们对"健康"的定义.
研究的目的:
- 在启动ETI后,探索pwCF中健康和幸福感的变化,超出预期的身体益处.
- 记录pwCF参与SIMPLIFY试验的定性经验.
主要方法:
- 通过SIMPLIFY试验 (QUEST) 研究,对经验的定性理解涉及到对pwCF进行深入采访.
- 两次60分钟的采访大约4个月间进行,录音,转录,并使用现象学方法进行分析.
- 开发了一个正式的代码书,以确定定性数据中的关键主题.
主要成果:
- 91名pwCF和23名护理人员参与了这项研究.
- 出现了四个主要主题:健康的显著改善 ("夜间和白天的变化"),认知负载的减少,转向管理整体健康和并发症,以及社会和自我身份的变化.
- 这些发现超出了ETI已知的物理益处.
结论:
- ETI提高了pwCF的健康期望.
- 现有的生活质量 (QOL) 和症状措施可能无法完全捕捉到pwCF在ETI上经历的细微变化.
- 囊性纤维化治疗应该适应包括更广泛的健康方面,包括并发症管理和未来规划.
相关概念视频
Cystic Fibrosis: Management
142
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
142
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Clinical Trials: Overview
2.8K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.8K
Drugs for Treatment of Ulcerative Colitis in IBD
120
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
120
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Antimicrobial Effectiveness
2
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
2


